Diffusion Pharmaceuticals Future Growth

How is Diffusion Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

21.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:DFFN - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	3	-15	N/A	N/A	1
12/31/2024	N/A	-18	N/A	N/A	2
12/31/2023	N/A	-17	N/A	N/A	2
9/30/2022	N/A	-15	-15	-15	N/A
6/30/2022	N/A	-24	-15	-15	N/A
3/31/2022	N/A	-24	-14	-14	N/A
12/31/2021	N/A	-24	-15	-15	N/A
9/30/2021	N/A	-25	-15	-15	N/A
6/30/2021	N/A	-17	-15	-15	N/A
3/31/2021	N/A	-18	-15	-15	N/A
12/31/2020	N/A	-16	-14	-14	N/A
9/30/2020	N/A	-16	-13	-13	N/A
6/30/2020	N/A	-14	-11	-11	N/A
3/31/2020	N/A	-12	-11	-11	N/A
12/31/2019	N/A	-12	-10	-10	N/A
9/30/2019	N/A	-14	-10	-10	N/A
6/30/2019	N/A	-18	-10	-10	N/A
3/31/2019	N/A	-18	-10	-10	N/A
12/31/2018	N/A	-27	-11	-11	N/A
9/30/2018	N/A	-20	-10	-10	N/A
6/30/2018	N/A	-10	-12	-12	N/A
3/31/2018	N/A	4	-13	-12	N/A
12/31/2017	N/A	-3	-13	-12	N/A
9/30/2017	N/A	-7	-12	-11	N/A
6/30/2017	N/A	-15	-10	-9	N/A
3/31/2017	N/A	-30	-10	-10	N/A
12/31/2016	N/A	-18	-11	-11	N/A
9/30/2016	N/A	-18	-12	-12	N/A
6/30/2016	N/A	-14	N/A	-11	N/A

Earnings vs Savings Rate: DFFN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DFFN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DFFN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DFFN is forecast to have no revenue next year.

High Growth Revenue: DFFN is forecast to have no revenue next year.

Future ROE: Insufficient data to determine if DFFN's Return on Equity is forecast to be high in 3 years time